Effects of hormone replacement therapy on the mammographic density of postmenopausal women undergoing screening mammography;Impatto della terapia ormonale sostitutiva in menopausa sulla densità radiologica della mammella e possibili implicazioni della mammografia nelle indagini di massa

Radiologia Medica

Volumn 101, Issue 1-2, 2001, Pages 39-43

  Ciatto, Stefano ^a   Bonardi, Rita ^b   Zappa, Marco ^a  

^a CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Breast, carcinoma; Hormone replacement therapy, mammography

Indexed keywords

AGED; ARTICLE; BREAST TUMOR; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAMMOGRAPHY; MENOPAUSE; MIDDLE AGED; RADIOGRAPHY;

AGED; BREAST NEOPLASMS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MAMMOGRAPHY; MENOPAUSE; MIDDLE AGED;

EID: 0035231021     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Beral V, Banks E, Reeves G. HRT and high incidence of breast cancer between mammographic screens. Lancet 319: 1103-1004, 1997.
2. Berkowitz JE, Gatewood OMB. Hormonal replacement therapy: mammographic manifestations. Radiology 174: 199-201, 1990.
3. Bird RE, Wallace TW, Yankaskas BC. Analysis of cancers missed at screening mammography. Radiology 184: 613-617, 1992.
4. Boyd NT, Byng JW, Jong RA e Coll. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 87: 670-675, 1995.
5. Byrne C, Schairer C, Wolfe J, e Coll. Mammographic features and breast cancer risk; effects with time, age, and menopause status. J Natl Cancer Inst 87: 1622-1929, 1995.
6. Byrne C. Studying mammographic density: implications for understanding breast cancer. J Natl Cancer Inst 89: 531-533, 1997.
7. Ciatto S, Zappa M. A prospective study of the value of mammographic patterns as indicators of breast cancer risk in a screening experience. Eur J Radiol 17: 122-125, 1993.
8. Ciatto S, Rosselli Del Turco M, Zappa M. The detectability of breast cancer by screening mammography. Br J Cancer 71: 337-339, 1995.
9. Colditz GA, Hankinson SE, Hunter DJ e Coll. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332: 1589-1593, 1995.
10. Del Favero C, Rossini G, Tufarulo L e Coll. Le modificazioni mammographiche nella terapia ormonale sostitutiva nelle pazienti dopo la menopausa. Radiol Med 93: 210-213, 1997.
11. Feig SA. Hormonal reduction of mammographic densities: potential effects on breast cancer risk and performance of diagnostic and screening mammography. J Natl cancer Inst 86: 408-409, 1994.
12. Holland R, Hendriks JHCL, Mravunac. Mammographically occult breast cancer. A pathologic and radiologic study. AJR 128: 403-408, 1983.
13. Kavanagh AM, Mitchell H, Giles GG. Hormone replacement therapy and accuracy of mammographic screening. Lancet 355: 270-274, 2000.
14. Laya MB, Gallagher JK, Schreiman JS e Coll. Effects of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology 196: 433-437, 1995.
15. Laya MB, Larson EB, Tpalin SH, White E. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J Natl Cancer Inst 88: 643-649, 1996.
16. Ma L, Fishell E, Wright B e Coll. Case control study of factors associated with failure to detect breast cancer by mammography. J Natl Cancer Inst 84: 781-785, 1992.
17. McNicholas MM, Hedneghan JP. Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study. AJR 163: 311-315, 1994.
18. Morrone D, Ambrogetti D, Bravetti P e Coll. L'errore nella mammografia - 1. I falsi negativi. Radiol Med 82: 212-217, 1991.
19. Porfiri LM, Costanza L. Valu-tazione mammografica delle variazioni morfostrutturali della ghiandola mammaria durante terapia sostitutiva nella menopausa. Radiol Med 95: 573-576, 1998
20. Roubidoux MA, Wilson TE. Breast cancer in women who undergo screening mammography. Relationship of hormone replacement therapy to stage and detecion method. Radiology 208: 725-728, 1998.
21. Stomper PC, D'Souza DJ, Diritto PA e Coll. Analysis of parenchymal density on mammograms in 1353 women 25-79 years old. AJR 167: 1261-1265, 1996.
22. Therfall AG, Woodman CBJ, Prior P. Breast screening programme: should the interval between tests depend on age? Lancet 319: 472, 1997.
23. Van Gils CH, Ottend JDM, Hendriks JHCL e Coll. High mammographic breast density and its implications for the early detection of breast cancer. J Med Screen 6: 200-204, 1999.